MedPath

福建省永安药业有限责任公司

Ownership
-
Established
1995-12-21
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

35

NMPA:35

Drug Approvals

Terbinafine Hydrochloride Cream

Product Name
盐酸特比萘芬乳膏
Approval Number
国药准字H20083586
Approval Date
May 20, 2024
NMPA

Compound Camphor Cream

Product Name
复方樟脑乳膏
Approval Number
国药准字H20065891
Approval Date
May 20, 2024
NMPA

Phenoxybenzamine Hydrochloride Tablets

Product Name
盐酸酚苄明片
Approval Number
国药准字H35020679
Approval Date
Feb 5, 2024
NMPA

Levodopa Tablets

Product Name
左旋多巴片
Approval Number
国药准字H35020674
Approval Date
Feb 5, 2024
NMPA

Proglumide Tablets

Product Name
丙谷胺片
Approval Number
国药准字H35020675
Approval Date
Feb 5, 2024
NMPA

Vitamin B1 Tablets

Product Name
维生素B1片
Approval Number
国药准字H35021086
Approval Date
Feb 5, 2024
NMPA

Vitamin C Tablets

Product Name
维生素C片
Approval Number
国药准字H35021087
Approval Date
Feb 5, 2024
NMPA

一扫光药膏

Approval Number
国药准字Z35020216
Approval Date
Feb 5, 2024
NMPA

Chlorphenamine Maleate Tablets

Product Name
马来酸氯苯那敏片
Approval Number
国药准字H35021084
Approval Date
Feb 5, 2024
NMPA

Naproxen Tablets

Product Name
萘普生片
Approval Number
国药准字H19983169
Approval Date
Feb 5, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.